Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer
Tài liệu tham khảo
Sternberg, 1987, Advances in the treatment of urothelial tract tumors, 373
Sternberg, 1989, Management of invasive bladder neoplasms, 95
Sternberg, 1989, Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell carcinoma of the urothelium, Efficacy and patterns of response and relapse. Cancer, 64, 2448
Harker, 1985, Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract, A Northern California Oncology Group Study. J Clin Oncol, 3, 1463, 10.1200/JCO.1985.3.11.1463
Stoter, 1987, Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder, J Urol, 137, 663, 10.1016/S0022-5347(17)44168-1
Sternberg, 1985, Carboplatin a new platinum analogue in the treatment of epidermoid carcinoma of the esophagus, Cancer Treat Rep, 69, 1305
Calvert, 1985, Phase II studies with carboplatin at the Royal Marsden Hospital, Cancer Treat Rev, 12, 51, 10.1016/0305-7372(85)90018-0
Kyriazis, 1985, Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum (II), diammine (1, 1-cyclobutanedicarboxylato (2-) o, o'platinum), and mitoguazone dihydrochloride, Cancer Research, 45, 2012
Forastiere, 1987, A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck, J Clin One, 5, 190, 10.1200/JCO.1987.5.2.190
Thorud, 1987, Phase I study with carboplatin and 5-FU patients with advanced head and neck carcino, 317
De Andres, 1987, Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in advanced head and neck canc, 956
Schroeder, 1987, Phase II trial with carboplatin/5-FU in previously untreated patients with advanced squamous cell carcinoma of the head and ne, 976
Venturini, 1989, Neoadjuvant or definitive alternating chemotherapy and radiotherapy for infiltrating bladder cancer, Am J Clin Oncol, 12, 63, 10.1097/00000421-198902000-00015
Gradishar, 1990, 5-Fluorouracil cardiotoxicity: A critical review, Ann Oncol, 1, 409, 10.1093/oxfordjournals.annonc.a057793
Creekmore, 1986, Antitumor activity of 24-hour CBDCA infusions in metastatic transitional cell carcino, 101
Marcuello, 1990, Carboplatin for advanced bladder cancer, Eur J Cancer, 26, 849, 10.1016/0277-5379(90)90172-P
Mechl, 1987, Phase II trial of carboplatin in advanced bladder canc, 63
Raabe, 1989, Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder, Br J Urol, 64, 607, 10.1111/j.1464-410X.1989.tb05318.x
Wit, 1991, Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer, Eur J Cancer, 27, 1383, 10.1016/0277-5379(91)90015-6
Azaka, 1989, Phase II trial of carboplatin in patients with advanced germ-cell testicular tumors and transitional cell carcinoma of the urinary tract, Cancer Chemother Pharmacol, 23, 181
1987, A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder, Eur J Cancer, 23, 375, 10.1016/0277-5379(87)90372-5
Germa, 1987, A phase II trial of carboplatin in advanced or metastatic transitional cell carcinoma of the bladde, 63
Trump, 1990, Randomized phase II evaluation of carboplatin and CHIP in advanced transitional cell carcinoma of the urothelium, J Urol, 144, 1119, 10.1016/S0022-5347(17)39672-6
Oliver, 1986, Methotrexate, cisplatin and carboplatin as single agents and in combination for metastatic bladder cancer, Br J Urol, 58, 31, 10.1111/j.1464-410X.1986.tb05423.x
Harland, 1988, 571
Stalder, 1990
Klocker, 1991, Carboplatin, methotrexate, and vinblastine (Carbo-MV) for advanced urothelial cancer, Am J Clin Oncol, 14, 328, 10.1097/00000421-199108000-00011
Ahmed, 1985, Vinblastine and methotrexate for advanced bladder cancer, J Urol, 133, 602, 10.1016/S0022-5347(17)49106-3
Waxman, 1989, New combination chemotherapy program for bladder cancer, Br J Urol, 63, 68, 10.1111/j.1464-410X.1989.tb05126.x
Egorin, 1984, Pharmacokinetics and dosage reduction of cis-diammine (1, 1-cyclobutane-dicarboxylato) platinum in patients with impaired renal function, Cancer Res, 44, 5432
Gabrilove, 1988, Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium, N Eng J Med, 318, 1414, 10.1056/NEJM198806023182202